- Trials with a EudraCT protocol (98)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
98 result(s) found for: Ewing's Sarcoma.
Displaying page 3 of 5.
| EudraCT Number: 2005-004272-20 | Sponsor Protocol Number: E7389-E044-207 | Start Date*: 2006-10-23 | |||||||||||
| Sponsor Name:Eisai Limited | |||||||||||||
| Full Title: Phase II Study of E7389 Administered as an IV Infusion Day 1 and 8 every 3 Weeks in Pretreated Patients with Advanced and/or Metastatic Soft Tissue Sarcoma Protocol Version 5.0 (2010-01-27) | |||||||||||||
| Medical condition: Advanced and/or metastatic soft tissue sarcoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) DE (Completed) DK (Completed) FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-000259-99 | Sponsor Protocol Number: RG_13-277 | Start Date*: 2014-08-29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:University of Birmingham | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Recurrent and refractory Ewing sarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) FI (Trial now transitioned) DK (Trial now transitioned) DE (Ongoing) HU (Completed) CZ (Trial now transitioned) FR (Trial now transitioned) BE (Trial now transitioned) NL (Trial now transitioned) PL (Completed) IT (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2011-003745-18 | Sponsor Protocol Number: GISG-04 | Start Date*: 2012-05-22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:University of Heidelberg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: A PHASE II WINDOW-OF-OPPORTUNITY STUDY OF PREOPERATIVE THERAPY WITH PAZOPANIB (VOTRIENT®) IN HIGH-RISK SOFT TISSUE SARCOMA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: High-risk soft tissue sarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2017-000095-28 | Sponsor Protocol Number: H3E-MC-JMHW | Start Date*: 2017-03-02 |
| Sponsor Name:Eli Lilly and Company | ||
| Full Title: A Phase II Study of Pemetrexed in Children with Recurrent Malignancies | ||
| Medical condition: Recurrent Malignancies (recurrent solid tumors): Target tumor types were osteosarcoma, Ewing sarcoma/peripheral PNET, rhabdomyosarcoma, neuroblastoma (measurable disease), neuroblastoma (metaiodob... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2009-017261-32 | Sponsor Protocol Number: KKSH077 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | |||||||||||||
| Full Title: Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma | |||||||||||||
| Medical condition: Relapsed or metastatic soft tissue sarcoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-001282-17 | Sponsor Protocol Number: E7389-G000-223 | Start Date*: 2018-03-23 |
| Sponsor Name:Eisai Inc. | ||
| Full Title: A Phase 2, Multicenter, Open-label Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma S... | ||
| Medical condition: Relapsed/Refractory Rhabdomyosarcoma Non-rhabdomyosarcoma Soft Tissue Sarcoma Ewing Sarcoma | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001861-40 | Sponsor Protocol Number: BRTA-0100-015 (EORTC 62061) | Start Date*: 2006-09-21 | |||||||||||
| Sponsor Name:SYSTEMS MEDICINE, LLC | |||||||||||||
| Full Title: Randomized phase II study of brostallicin (PNU-166196A) versus doxorubicin as first line chemotherapy in patients with advanced or metastatic soft tissue sarcoma | |||||||||||||
| Medical condition: Advanced or metastatic soft tissue sarcoma. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) DE (Completed) GB (Completed) NL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-004856-57 | Sponsor Protocol Number: IPM2002 | Start Date*: 2008-12-31 | |||||||||||
| Sponsor Name:ZIOPHARM ONCOLOGY, INC | |||||||||||||
| Full Title: A Phase II multicenter, parallel group, randomized study of palIfosfamide tris plus doxorubiCin versus doxorubicin in subjects with unresectAble or metastatic Soft-tissue SarcOma (PICASSO) | |||||||||||||
| Medical condition: Unresectable or metastatic soft-tissue sarcoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-014889-26 | Sponsor Protocol Number: EORTC 62091 | Start Date*: 2011-12-15 | |||||||||||
| Sponsor Name:EORTC (European Organisation for Research and Treatment of Cancer) | |||||||||||||
| Full Title: TRUSTS: A phase IIb/III multicenter study comparing the efficacy of TRabectedin administered as a 3-hour or 24-hour infusion to doxorubicin in patients with advanced or metastatic Untreated Soft Ti... | |||||||||||||
| Medical condition: Histologically proven advanced and/or metastatic malignant soft tissue sarcoma intermediate/high grade, excluding the following tumor types : Well-differentiated liposarcoma Embryonal rhabdomyo... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) DE (Completed) BE (Completed) HU (Completed) DK (Completed) AT (Completed) NL (Completed) SK (Completed) ES (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-018851-88 | Sponsor Protocol Number: IPR/23 | Start Date*: 2010-09-27 | |||||||||||
| Sponsor Name:MOLMED | |||||||||||||
| Full Title: NGR016: Randomized phase II study evaluating two doses of NGR-hTNF administered either as single agent or in combination with doxorubicin in patients with advanced soft-tissue sarcoma (STS). | |||||||||||||
| Medical condition: Locally advanced or metastatic STS patients untreated or previously treated with one or more prior systemic regimen. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-016027-62 | Sponsor Protocol Number: GEIS-21 | Start Date*: 2010-02-11 |
| Sponsor Name:GRUPO ESPAÑOL DE INVESTIGACION EN SARCOMAS | ||
| Full Title: ENSAYO CLÍNICO, FASE II, ABIERTO, NO CONTROLADO, MULTICÉNTRICO Y PROSPECTIVO, DE QUIMIOTERAPIA INTENSIVA, CIRUGÍA Y RADIOTERAPIA EN SARCOMA DE EWING DE NIÑOS Y ADULTOS JÓVENES | ||
| Medical condition: Pacientes niños y adultos jóvenes con sarcoma de Ewing | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-004750-15 | Sponsor Protocol Number: AIO-STS-0415 | Start Date*: 2017-10-06 | ||||||||||||||||
| Sponsor Name:AIO-Studien-gGmbH | ||||||||||||||||||
| Full Title: A randomized phase II study of Durvalumab (MEDI4736) and Tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma. | ||||||||||||||||||
| Medical condition: advanced or metastatic soft tissue sarcoma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2020-002579-37 | Sponsor Protocol Number: Metformina-Bone | Start Date*: 2020-11-18 | ||||||||||||||||
| Sponsor Name:ISTITUTO ORTOPEDICO RIZZOLI | ||||||||||||||||||
| Full Title: Metformin as maintenance therapy in bone sarcomas at high risk of relapse | ||||||||||||||||||
| Medical condition: Osteosarcoma and Ewing's Sarcoma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: IT (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2018-004104-19 | Sponsor Protocol Number: PH-L19TNFSARC-03/18 | Start Date*: 2020-02-12 | |||||||||||
| Sponsor Name:Philogen S.p.A. | |||||||||||||
| Full Title: A randomized study to investigate the efficacy and safety of the tumor-targeting human antibody-cytokine fusion protein L19TNF in previously treated patients with advanced stage or metastatic soft-... | |||||||||||||
| Medical condition: Unresectable and/or metastatic soft-tissue sarcoma after failure of at least two prior systemic therapy regimens | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Trial now transitioned) PL (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-005017-19 | Sponsor Protocol Number: BO20924 | Start Date*: 2008-06-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Open-label, multi-center, randomized, phase II study evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients presenting with metastatic rhabdomyosarcoma and non-... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Patients aged 6 months to <18 years, presenting with metastatic rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcoma. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) FR (Completed) NL (Completed) IT (Completed) BE (Completed) ES (Completed) PL (Completed) DE (Completed) CZ (Completed) Outside EU/EEA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2007-001152-39 | Sponsor Protocol Number: SSG XX | Start Date*: 2024-05-21 |
| Sponsor Name:Scandinavian Sarcoma Group | ||
| Full Title: SSGXX A Scandinavian Sarcoma Group treatment protocol for adult patients with non-metastatic high-risk soft tissue sarcoma of the extremities and trunk wall | ||
| Medical condition: SSG XX is a phase II trial for high-risk soft tissue sarcoma(STS) of the extremities and trunk wall. Prognostic markers are used to identify high-risk tumors. SSG XX will evaluate chemo-and radioth... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Completed) SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-001478-10 | Sponsor Protocol Number: Z3 | Start Date*: 2009-02-01 | |||||||||||
| Sponsor Name:Universitätsklinikum Tübingen | |||||||||||||
| Full Title: CWS-2007-HR: A randomised phase-III trial of the Cooperative Weichteilsarkom Studiengruppe for localised high-risk Rhabdomyosarcoma and localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in childr... | |||||||||||||
| Medical condition: localized High Risk Soft Tissue Sarcoma in patients younger than 21 years | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) AT (Completed) SE (Completed) PL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-000364-16 | Sponsor Protocol Number: CELYVIR | Start Date*: 2011-02-07 |
| Sponsor Name:FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO NIÑO JESUS | ||
| Full Title: Ensayo clínico abierto de fase I para evaluar la eficacia y seguridad del tratamiento con células mesenquimales autólogas infectadas con un nuevo adenovirus oncolítico en el tratamiento de paciente... | ||
| Medical condition: Niños con tumor sólido refractario o recidivante a dos o más líneas de tratamiento estándar de los siguientes diagnósticos histológicos: neuroblastoma estadio IV, sarcoma de Ewing con metástasis ós... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-002176-34 | Sponsor Protocol Number: GEIS01-07 | Start Date*: 2007-07-27 | |||||||||||
| Sponsor Name:GEIS | |||||||||||||
| Full Title: Ensayo clínico de fase I-II, no aleatorizado, multicentrico para evaluar la seguridad y la eficacia de la combinación de sorafenib (BAY 43-9006) e ifosfamida en el tratamiento de pacientes con sarc... | |||||||||||||
| Medical condition: Pacientes diagnosticados de sarcoma de partes blandas avanzado que previamente hayan recibido antraciclinas o que no sean candidatos a tratamiento con antraciclinas. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-001709-24 | Sponsor Protocol Number: FIICGDTIC | Start Date*: 2005-08-24 |
| Sponsor Name:Grupo Español de Investigación en Sarcomas (GEIS) | ||
| Full Title: Estudio en fase II, abierto, multicéntrico, prospectivo y aleatorizado, con DTIC o la combinación de Gemcitabina y DTIC en sarcomas de partes blandas avanzados del adulto | ||
| Medical condition: Sarcomas de partes blandas | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
